154 related articles for article (PubMed ID: 37278682)
1. 1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants.
Gillespie MJ; McElhinney DB; Jones TK; Levi DS; Asnes J; Gray RG; Cabalka AK; Fujimoto K; Qureshi AM; Justino H; Bergersen L; Benson LN; Haugan D; Boe BA; Cheatham JP
JACC Cardiovasc Interv; 2023 Aug; 16(15):1917-1928. PubMed ID: 37278682
[TBL] [Abstract][Full Text] [Related]
2. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.
Benson LN; Gillespie MJ; Bergersen L; Cheatham SL; Hor KN; Horlick EM; Weng S; McHenry BT; Osten MD; Powell AJ; Cheatham JP
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008320. PubMed ID: 32525412
[TBL] [Abstract][Full Text] [Related]
3. Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve.
Bergersen L; Benson LN; Gillespie MJ; Cheatham SL; Crean AM; Hor KN; Horlick EM; Lung TH; McHenry BT; Osten MD; Powell AJ; Cheatham JP
JACC Cardiovasc Interv; 2017 Sep; 10(17):1763-1773. PubMed ID: 28882284
[TBL] [Abstract][Full Text] [Related]
4. Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve.
Shahanavaz S; Berger F; Jones TK; Kreutzer J; Vincent JA; Eicken A; Bergersen L; Rome JJ; Zahn E; Søndergaard L; Cheatham JP; Weng S; Balzer D; McElhinney D
JACC Cardiovasc Interv; 2020 Jul; 13(13):1529-1540. PubMed ID: 32646693
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment.
Steinberg ZL; Cabalka AK; Balzer DT; Asnes JD; Morray BH; Gillespie MJ; McElhinney DB
Catheter Cardiovasc Interv; 2023 Nov; 102(6):1078-1087. PubMed ID: 37925624
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.
Armstrong AK; Balzer DT; Cabalka AK; Gray RG; Javois AJ; Moore JW; Rome JJ; Turner DR; Zellers TM; Kreutzer J
JACC Cardiovasc Interv; 2014 Nov; 7(11):1254-62. PubMed ID: 25459038
[TBL] [Abstract][Full Text] [Related]
7. Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry.
Goldstein BH; McElhinney DB; Gillespie MJ; Aboulhosn JA; Levi DS; Morray BH; Cabalka AK; Love BA; Zampi JD; Balzer DT; Law MA; Schiff MD; Hoskoppal A; Qureshi AM
J Am Coll Cardiol; 2024 Apr; 83(14):1310-1321. PubMed ID: 38569760
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.
Cabalka AK; Asnes JD; Balzer DT; Cheatham JP; Gillespie MJ; Jones TK; Justino H; Kim DW; Lung TH; Turner DR; McElhinney DB
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1712-1724.e1. PubMed ID: 29395214
[TBL] [Abstract][Full Text] [Related]
9. Patient Selection Process for the Harmony Transcatheter Pulmonary Valve Early Feasibility Study.
Gillespie MJ; Benson LN; Bergersen L; Bacha EA; Cheatham SL; Crean AM; Eicken A; Ewert P; Geva T; Hellenbrand WE; Hor KN; Horlick EM; Jones TK; Mayer J; McHenry BT; Osten MD; Powell AJ; Zahn EM; Cheatham JP
Am J Cardiol; 2017 Oct; 120(8):1387-1392. PubMed ID: 28823485
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract.
Jin Q; Long Y; Zhang G; Pan X; Chen M; Feng Y; Liu J; Yu S; Pan W; Zhou D; Ge J
Catheter Cardiovasc Interv; 2024 Feb; 103(2):359-366. PubMed ID: 38054354
[TBL] [Abstract][Full Text] [Related]
11. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial.
Cheatham JP; Hellenbrand WE; Zahn EM; Jones TK; Berman DP; Vincent JA; McElhinney DB
Circulation; 2015 Jun; 131(22):1960-70. PubMed ID: 25944758
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter Pulmonary Valve Replacement With the Harmony Valve in Patients Who Do Not Meet Recommended Oversizing Criteria on the Screening Perimeter Plot.
McElhinney DB; Gillespie MJ; Aboulhosn JA; Cabalka AK; Morray BH; Balzer DT; Qureshi AM; Hoskoppal AK; Goldstein BH
Circ Cardiovasc Interv; 2024 May; 17(5):e013889. PubMed ID: 38606564
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.
Jones TK; McElhinney DB; Vincent JA; Hellenbrand WE; Cheatham JP; Berman DP; Zahn EM; Khan DM; Rhodes JF; Weng S; Bergersen LJ
Circ Cardiovasc Interv; 2022 Jan; 15(1):e010852. PubMed ID: 34930015
[TBL] [Abstract][Full Text] [Related]
14. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.
Markham R; Challa A; Kyranis S; Nicolae M; Murdoch D; Savage M; Malpas T; Radford DJ; Hamilton-Craig C; Walters DL
Heart Lung Circ; 2017 Oct; 26(10):1085-1093. PubMed ID: 28185817
[TBL] [Abstract][Full Text] [Related]
15. Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction: An Early Feasibility Study.
Shahanavaz S; Balzer D; Babaliaros V; Kim D; Dimas V; Veeram Reddy SR; Leipsic J; Blanke P; Shirali G; Parthiban A; Gorelick J; Zahn EM
JACC Cardiovasc Interv; 2020 Nov; 13(21):2510-2524. PubMed ID: 33069657
[TBL] [Abstract][Full Text] [Related]
16. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.
Kenny D; Rhodes JF; Fleming GA; Kar S; Zahn EM; Vincent J; Shirali GS; Gorelick J; Fogel MA; Fahey JT; Kim DW; Babaliaros VC; Armstrong AK; Hijazi ZM
JACC Cardiovasc Interv; 2018 Oct; 11(19):1920-1929. PubMed ID: 30286853
[TBL] [Abstract][Full Text] [Related]
17. Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
Morray BH; Jones TK; Coe JY; Gitter R; Martinez JZ; Turner DR; Gray RG; Lung TH; Berman DP; Levi DS
Catheter Cardiovasc Interv; 2019 Feb; 93(3):474-480. PubMed ID: 30419603
[TBL] [Abstract][Full Text] [Related]
18. Right Ventricular Outflow Tract Reconstruction With a Polytetrafluoroethylene Monocusp Valve: A 20-Year Experience.
Kumar M; Turrentine MW; Rodefeld MD; Bell T; Brown JW
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):463-470. PubMed ID: 28043462
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
Kang SL; Ramroop R; Manojlovich L; Runeckles K; Fan S; Chaturvedi RR; Lee KJ; Benson LN
Catheter Cardiovasc Interv; 2022 Mar; 99(4):1138-1148. PubMed ID: 34967102
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
Rodríguez Ogando A; Ballesteros F; Martínez JLZ
Catheter Cardiovasc Interv; 2022 Jan; 99(1):E38-E42. PubMed ID: 34674370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
